Article
BECN1 and BIM interactions with MCL-1 determine fludarabine resistance in leukemic B cells
16 May 2013
Abstract excerpt
The purine analog fludarabine (Fd) is an essential therapeutic for chronic lymphocytic leukemia (CLL). Innate or acquired resistance to Fd is a significant clinical problem and is largely mediated by increased expression of BCL-2 family members. The antiapoptotic BCL-2 family proteins inhibit both apoptosis and autophagy, therefore, downregulation of antiapoptotic BCL-2 family proteins and enhanced autophagy must...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
